Yakun Wan

shanghai novamab biopharmaceuticals co, ltd

H指数:32

被引数:2,781

浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Structural mechanism of the agonist binding on human TRPC3 channel

人源TRPC3通道激动剂结合的结构机制

Nature Communications

IF15.7

2025-10-220

OAAI

Potassium-Based Metal-Organic Framework with Coordination-Induced Electrochemiluminescence for Biosensing Applications

具有配位诱导电化学发光的钾基金属有机框架在生物传感中的应用

Advanced Functional Materials

IF19

2025-07-210

PRE

Nanobody-engineered bispecific IL-18 mimetics drive antitumor immunity by engaging CD8+ T cell and evading IL-18BP in preclinical models

Nanobody-engineered bispecific IL-18 mimetics通过结合CD8+ T细胞并逃避IL-18BP，在临床前模型中驱动抗肿瘤免疫。

Molecular Therapy

IF12

2025-07-170

PRE

177a: FIRST-IN-CLASS ORAL TL1A NANOBODY AND LONG-ACTING TL1A/IL-23 BISPECIFIC NANOBODY: NOVEL THERAPIES FOR INFLAMMATORY BOWEL DISEASE

177a: 首创口服TL1A纳米抗体和长效TL1A/IL-23双特异性纳米抗体：炎症性肠病的新型疗法

Gastroenterology

IF25.1

2025-07-030

PRE

Ce-MOF@Au-Based Electrochemical Immunosensor for Apolipoprotein A1 Detection Using Nanobody Technology

ACS APPLIED MATERIALS & INTERFACES

IF8.2

2024-10-161

PRE

A novel inhalable nanobody targeting IL-4Ra for the treatment of asthma

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

IF11.2

2024-10-010

PRE

Neutrophil extracellular traps: Potential targets for the treatment of rheumatoid arthritis with traditional Chinese medicine and natural products

中性粒细胞胞外诱捕网: 中药及天然产物治疗类风湿性关节炎的潜在靶点

PHYTOTHERAPY RESEARCH

IF6.3

2024-08-060

PRE

Development and validation of a predictive model assessing the risk of sarcopenia in rheumatoid arthritis patients

类风湿关节炎患者肌少症风险预测模型的构建与验证

FRONTIERS IN IMMUNOLOGY

IF5.9

2024-07-291

OAAI

Nanobody-Based Microfluidic Immunosensor Chip Using Tetraphenylethylene-Derived Covalent Organic Frameworks as Aggregation-Induced Electrochemiluminescence Emitters for the Detection of Thymic Stromal Lymphopoietin

ANALYTICAL CHEMISTRY

IF6.7

2024-06-1028

PRE

A humanized trivalent Nectin-4-targeting nanobody drug conjugate displays potent antitumor activity in gastric cancer

人源化三价Nectin-4-targeting纳米抗体药物偶联物在胃癌中显示出有效的抗肿瘤活性

JOURNAL OF NANOBIOTECHNOLOGY

IF12.6

2024-05-162

OAAI

TROP2-directed nanobody-drug conjugate elicited potent antitumor effect in pancreatic cancer

JOURNAL OF NANOBIOTECHNOLOGY

IF12.6

2023-11-0614

OAAI

Late Breaking Abstract - Phase I safety and tolerance study of the inhalable anti IL-4Rα single domain antibody, LQ036, demonstrates promising clinical profile to treat asthma

EUROPEAN RESPIRATORY JOURNAL

IF21

2023-10-271

PRE

Role of the Histone Variant H2A.Z/Htz1p in TBP Recruitment, Chromatin Dynamics, and Regulated Expression of Oleate-Responsive Genes

MOLECULAR AND CELLULAR BIOLOGY

IF2.7

2023-03-2182

OAAI

Online health estimation strategy with transfer learning for operating lithium-ion batteries

基于迁移学习的锂离子电池在线健康评估策略

iet power electronics

IF1.3

2023-02-168

PRE

Screening, Expression, and Identification of Nanobody against SARS-CoV-2 Spike Protein

CELLS

IF5.2

2022-10-247

OAAI

PD-L1/TLR7 dual-targeting nanobody-drug conjugate mediates potent tumor regression via elevating tumor immunogenicity in a host-expressed PD-L1 bias-dependent way

JOURNAL FOR IMMUNOTHERAPY OF CANCER

IF10.6

2022-10-1727

OAAI

Preclinical evaluation of [99mTc]Tc-labeled anti-EpCAM nanobody for EpCAM receptor expression imaging by immuno-SPECT/CT

European Journal of Nuclear Medicine and Molecular Imaging

IF7.6

2022-01-1113

Metabolic modulation via mTOR pathway and anti-angiogenesis remodels tumor microenvironment using PD-L1-targeting codelivery

BIOMATERIALS

IF12.9

2020-10-0194

PREAI

Preclinical development of a novel CD47 nanobody with less toxicity and enhanced anti-cancer therapeutic potential

JOURNAL OF NANOBIOTECHNOLOGY

IF12.6

2020-01-1381

OAAI

Remodeling Tumor-Associated Macrophages and Neovascularization Overcomes EGFRT790M-Associated Drug Resistance by PD-L1 Nanobody-Mediated Codelivery

SMALL

IF12.1

2018-10-1159

PREAI

Yakun Wan

个人简介

教育背景

工作经历

荣誉奖项

研究方向